Trials / Completed
CompletedNCT04515095
Water-only Fasting in the Treatment of Hypertension Patients
A Safety and Feasibility Study of Water-only Fasting and Refeeding for Treatment of Stage 1 and 2 Hypertensive Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- TrueNorth Health Foundation · Academic / Other
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This purpose of this study is to examine the safety and feasibility of water-only fasting to treat hypertensive patients.
Detailed description
This is a prospective, open label, single arm, intervention study to examine the safety and feasibility of water-only fasting to treat hypertensive patients. Additional aims include describing mean changes in resting blood pressure as well as markers of cardiovascular health and inflammation between baseline and end of fast, end of refeed, 6-weeks post departure, and 12-months after 6-weeks follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Water-only Fasting | Participants consume only water for at least 7 days in an in-patient, residential setting with 24 hour medical supervision. |
Timeline
- Start date
- 2020-08-16
- Primary completion
- 2021-09-29
- Completion
- 2022-12-01
- First posted
- 2020-08-17
- Last updated
- 2023-11-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04515095. Inclusion in this directory is not an endorsement.